The Drug Supply Chain Security Act (DSCSA) will ensure the complete traceability of prescription drugs at all levels of the supply chain in order to combat counterfeits in the industry, coming into full effect in just six months’ time.

With only six months to go until the active enforcement of DSCSA, there is little time left for manufacturers to implement any real changes.

With the deadline just around the corner, CDMOs should be already implementing their strategies in order to ensure compliance.

Staffan Widengren, director corporate projects at Recipharm, spoke to Manufacturing Chemist on the impending deadline and breaking down the financial barrier many companies are experiencing.

For the full article see here